MicroRNA‐34a Mediates the Aldosterone‐Induced Acceleration of Endothelial Senescence

Inappropriate aldosterone production relative to sodium status is known to induce arterial hypertension and cause detrimental effects on endothelium and vascular remodeling. This study investigated whether microRNAs (miRs) serve as key mediators of aldosterone’s effects on endothelial dysfunction. U...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of hypertension Vol. 2025; no. 1; p. 2339598
Main Authors Jia, Minyue, Lin, Liya, Yang, Boyun, Yu, Hanxiao, Zhong, Shan, Xu, Xiaohong, Song, Xiaoxiao
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.01.2025
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Inappropriate aldosterone production relative to sodium status is known to induce arterial hypertension and cause detrimental effects on endothelium and vascular remodeling. This study investigated whether microRNAs (miRs) serve as key mediators of aldosterone’s effects on endothelial dysfunction. Using human umbilical vein endothelial cells (HUVECs) as a model system, we demonstrated that aldosterone treatment suppressed cellular proliferation and migration while promoting senescence. Mechanistically, we observed that aldosterone exposure significantly upregulated miR‐34a expression in HUVECs. The functional significance of miR‐34a was confirmed when specific inhibitors reversed aldosterone’s antiproliferative and prosenescence effects. To elucidate the underlying molecular pathway, we performed comprehensive biological analyses, which revealed that miR‐34a target genes were predominantly associated with the Notch signaling pathway. Western blot analysis further validated that miR‐34a promotes senescence in HUVECs through negative regulation of NOTCH1. Collectively, our findings identify miR‐34a as a crucial mediator of aldosterone‐induced endothelial cell senescence via the NOTCH1 signaling pathway, suggesting its potential as a therapeutic target for aldosterone‐related vascular diseases.
AbstractList Inappropriate aldosterone production relative to sodium status is known to induce arterial hypertension and cause detrimental effects on endothelium and vascular remodeling. This study investigated whether microRNAs (miRs) serve as key mediators of aldosterone's effects on endothelial dysfunction. Using human umbilical vein endothelial cells (HUVECs) as a model system, we demonstrated that aldosterone treatment suppressed cellular proliferation and migration while promoting senescence. Mechanistically, we observed that aldosterone exposure significantly upregulated miR-34a expression in HUVECs. The functional significance of miR-34a was confirmed when specific inhibitors reversed aldosterone's antiproliferative and prosenescence effects. To elucidate the underlying molecular pathway, we performed comprehensive biological analyses, which revealed that miR-34a target genes were predominantly associated with the Notch signaling pathway. Western blot analysis further validated that miR-34a promotes senescence in HUVECs through negative regulation of NOTCH1. Collectively, our findings identify miR-34a as a crucial mediator of aldosterone-induced endothelial cell senescence via the NOTCH1 signaling pathway, suggesting its potential as a therapeutic target for aldosterone-related vascular diseases.
Inappropriate aldosterone production relative to sodium status is known to induce arterial hypertension and cause detrimental effects on endothelium and vascular remodeling. This study investigated whether microRNAs (miRs) serve as key mediators of aldosterone's effects on endothelial dysfunction. Using human umbilical vein endothelial cells (HUVECs) as a model system, we demonstrated that aldosterone treatment suppressed cellular proliferation and migration while promoting senescence. Mechanistically, we observed that aldosterone exposure significantly upregulated miR-34a expression in HUVECs. The functional significance of miR-34a was confirmed when specific inhibitors reversed aldosterone's antiproliferative and prosenescence effects. To elucidate the underlying molecular pathway, we performed comprehensive biological analyses, which revealed that miR-34a target genes were predominantly associated with the Notch signaling pathway. Western blot analysis further validated that miR-34a promotes senescence in HUVECs through negative regulation of NOTCH1. Collectively, our findings identify miR-34a as a crucial mediator of aldosterone-induced endothelial cell senescence via the NOTCH1 signaling pathway, suggesting its potential as a therapeutic target for aldosterone-related vascular diseases.Inappropriate aldosterone production relative to sodium status is known to induce arterial hypertension and cause detrimental effects on endothelium and vascular remodeling. This study investigated whether microRNAs (miRs) serve as key mediators of aldosterone's effects on endothelial dysfunction. Using human umbilical vein endothelial cells (HUVECs) as a model system, we demonstrated that aldosterone treatment suppressed cellular proliferation and migration while promoting senescence. Mechanistically, we observed that aldosterone exposure significantly upregulated miR-34a expression in HUVECs. The functional significance of miR-34a was confirmed when specific inhibitors reversed aldosterone's antiproliferative and prosenescence effects. To elucidate the underlying molecular pathway, we performed comprehensive biological analyses, which revealed that miR-34a target genes were predominantly associated with the Notch signaling pathway. Western blot analysis further validated that miR-34a promotes senescence in HUVECs through negative regulation of NOTCH1. Collectively, our findings identify miR-34a as a crucial mediator of aldosterone-induced endothelial cell senescence via the NOTCH1 signaling pathway, suggesting its potential as a therapeutic target for aldosterone-related vascular diseases.
Audience Academic
Author Jia, Minyue
Song, Xiaoxiao
Yang, Boyun
Zhong, Shan
Lin, Liya
Yu, Hanxiao
Xu, Xiaohong
Author_xml – sequence: 1
  givenname: Minyue
  orcidid: 0000-0002-4451-4973
  surname: Jia
  fullname: Jia, Minyue
– sequence: 2
  givenname: Liya
  orcidid: 0009-0002-6644-1274
  surname: Lin
  fullname: Lin, Liya
– sequence: 3
  givenname: Boyun
  orcidid: 0000-0001-6221-2461
  surname: Yang
  fullname: Yang, Boyun
– sequence: 4
  givenname: Hanxiao
  orcidid: 0009-0001-8700-2943
  surname: Yu
  fullname: Yu, Hanxiao
– sequence: 5
  givenname: Shan
  orcidid: 0000-0003-3277-9226
  surname: Zhong
  fullname: Zhong, Shan
– sequence: 6
  givenname: Xiaohong
  orcidid: 0000-0003-2157-2609
  surname: Xu
  fullname: Xu, Xiaohong
– sequence: 7
  givenname: Xiaoxiao
  orcidid: 0000-0001-5911-3307
  surname: Song
  fullname: Song, Xiaoxiao
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40226530$$D View this record in MEDLINE/PubMed
BookMark eNptks9uVCEUxompsbV259rcxKRx4bRc_tyB5U1TdZJWE-3CHeHCocOEgQr3LrrzEXxGn0SmM47WCCQQ-PHBOed7jg5iioDQyxaftS3n5361vD8nlEouxRN0RLDEM0wFO9ivJTlEJ6WscG1U1iGeoUOGCek4xUfo67U3OX3-2P_8_oMy3VyD9XqE0oxLaPpgUxkh1zfr8SLayYBtemMgQNajT7FJrrmMNlU6eB2aLxChGIgGXqCnTocCJ7v5GN28u7y5-DC7-vR-cdFfzQzDYpwJw4zFDgwDPQDvsDG6A-vqP40hzkg2mFYKPEhH5_NWAEDHB8cc0Ra6OT1Gi62sTXql7rJf63yvkvbqYSPlW6Xz6E0AJTvOiBk0wEBYDV5I5xzpOgpaDgNA1Xqz1brL6dsEZVRrX4MJQUdIU1G0FVKSVnBR0df_oKs05VgDfaA4ExJ3f6hbXd_30aUxa7MRVb2gnBIh8Ebr7D9U7RbW3tTcO1_3H104_evCEnQYlyWFaVOQ8hh8tfvlNKzB7tPzu_wVeLsFqgdKyeD2SIvVxmBqYzC1Mxj9BX4Qwnk
Cites_doi 10.1097/md.0000000000033724
10.1111/j.1476-5381.2012.02194.x
10.18632/aging.102625
10.1161/01.cir.0000153339.27064.14
10.1161/hypertensionaha.111.196832
10.2144/000113083
10.1161/atvbaha.118.311298
10.1161/01.cir.0000131860.80444.ab
10.1038/cddis.2017.495
10.1161/01.cir.0000013836.85741.17
10.1161/01.hyp.0000154365.30593.d3
10.1016/j.yjmcc.2017.11.015
10.1152/ajpendo.00192.2010
10.1016/j.cell.2019.10.005
10.1073/pnas.0707351104
10.1152/ajpcell.00415.2006
10.26355/eurrev_201902_16978
10.18332/tid/140095
10.1007/s10522-007-9082-x
10.2174/13894501113149990191
10.1016/j.vph.2020.106763
10.3389/fphar.2021.758792
10.1161/01.res.0000256837.40544.4a
10.1016/j.toxlet.2017.07.216
10.1038/cdd.2009.56
10.1210/en.2010-0829
10.1073/pnas.0801613105
10.1038/nrd.2017.116
10.1016/j.febslet.2012.12.021
10.1002/2211-5463.12496
10.1016/j.bbamcr.2011.07.010
10.1038/s41568-022-00450-9
10.1038/ncb3397
10.1016/j.bbrc.2010.07.012
10.1093/gerona/glu180
10.1038/nature11919
10.1155/2022/1388415
10.3390/ijms20205214
10.1158/0008-5472.can-07-2780
10.1038/nrg1990
10.1152/ajpcell.00203.2012
10.12659/msm.920678
10.1615/critreveukaryotgeneexpr.2015015396
10.1291/hypres.31.1407
10.1007/s00018-021-03979-4
10.1097/hjh.0b013e328013f492
10.1016/j.bbrc.2009.06.075
10.1186/s13046-019-1059-5
10.1371/journal.pone.0100359
10.1113/jp272512
10.3390/antiox8090328
10.1097/fjc.0b013e31828c090e
10.1038/srep31758
10.1038/nrg3272
10.1016/j.jsbmb.2011.12.014
10.3389/fcvm.2021.784044
10.1111/ggi.13927
10.1155/2017/2872156
ContentType Journal Article
Copyright Copyright © 2025 Minyue Jia et al. International Journal of Hypertension published by John Wiley & Sons Ltd.
COPYRIGHT 2025 John Wiley & Sons, Inc.
Copyright © 2025 Minyue Jia et al. International Journal of Hypertension published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (the “License”), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
Copyright_xml – notice: Copyright © 2025 Minyue Jia et al. International Journal of Hypertension published by John Wiley & Sons Ltd.
– notice: COPYRIGHT 2025 John Wiley & Sons, Inc.
– notice: Copyright © 2025 Minyue Jia et al. International Journal of Hypertension published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (the “License”), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
DBID AAYXX
CITATION
NPM
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOA
DOI 10.1155/ijhy/2339598
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
Research Library Prep
ProQuest Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
Publicly Available Content Database

MEDLINE - Academic

CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2090-0384
2090-0392
Editor Emanuele Pivetta
Editor_xml – fullname: Emanuele Pivetta
ExternalDocumentID oai_doaj_org_article_96542cbaeeb2453089fff2663ea9bbee
A835328808
40226530
10_1155_ijhy_2339598
Genre Journal Article
GeographicLocations North Carolina
China
United States--US
Germany
GeographicLocations_xml – name: China
– name: North Carolina
– name: United States--US
– name: Germany
GroupedDBID 0R~
188
24P
2UF
53G
5VS
8G5
AAFWJ
AAJEY
AAWTL
AAYXX
ABDBF
ABUWG
ACCMX
ACUHS
ADBBV
ADRAZ
AFKRA
AFPKN
AINHJ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
EBS
EJD
ESX
GNUQQ
GROUPED_DOAJ
GUQSH
H13
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
M2O
M48
O5R
O5S
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
RPM
TR2
TUS
UZ5
CEFSP
CNMHZ
NPM
PMFND
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
ID FETCH-LOGICAL-c408t-8c4cd0fec4eabe560cca6edf398cc2fc94bc1980b9f37718eee65bf4f2ade673
IEDL.DBID M48
ISSN 2090-0392
2090-0384
IngestDate Wed Aug 27 01:27:13 EDT 2025
Fri Jul 11 18:41:38 EDT 2025
Fri Jul 25 20:59:13 EDT 2025
Tue Jun 17 21:56:23 EDT 2025
Tue Jun 10 20:58:49 EDT 2025
Thu May 22 21:23:35 EDT 2025
Wed Apr 16 05:37:44 EDT 2025
Tue Jul 01 05:24:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords microRNA-34a
NOTCH1
cellular senescence
endothelial dysfunction
aldosterone
Language English
License Copyright © 2025 Minyue Jia et al. International Journal of Hypertension published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c408t-8c4cd0fec4eabe560cca6edf398cc2fc94bc1980b9f37718eee65bf4f2ade673
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0009-0002-6644-1274
0000-0003-2157-2609
0009-0001-8700-2943
0000-0001-6221-2461
0000-0003-3277-9226
0000-0001-5911-3307
0000-0002-4451-4973
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/ijhy/2339598
PMID 40226530
PQID 3189548906
PQPubID 2037457
ParticipantIDs doaj_primary_oai_doaj_org_article_96542cbaeeb2453089fff2663ea9bbee
proquest_miscellaneous_3189921858
proquest_journals_3189548906
gale_infotracmisc_A835328808
gale_infotracacademiconefile_A835328808
gale_healthsolutions_A835328808
pubmed_primary_40226530
crossref_primary_10_1155_ijhy_2339598
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-01-01
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle International journal of hypertension
PublicationTitleAlternate Int J Hypertens
PublicationYear 2025
Publisher John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley
References e_1_2_14_52_2
e_1_2_14_50_2
e_1_2_14_10_2
e_1_2_14_33_2
e_1_2_14_56_2
e_1_2_14_12_2
e_1_2_14_31_2
e_1_2_14_54_2
e_1_2_14_14_2
e_1_2_14_37_2
e_1_2_14_16_2
e_1_2_14_35_2
e_1_2_14_58_2
e_1_2_14_28_2
e_1_2_14_4_2
e_1_2_14_6_2
e_1_2_14_8_2
e_1_2_14_41_2
e_1_2_14_2_2
e_1_2_14_22_2
e_1_2_14_45_2
e_1_2_14_20_2
e_1_2_14_43_2
e_1_2_14_26_2
e_1_2_14_49_2
e_1_2_14_24_2
e_1_2_14_47_2
e_1_2_14_17_2
e_1_2_14_19_2
e_1_2_14_30_2
e_1_2_14_51_2
e_1_2_14_34_2
e_1_2_14_55_2
e_1_2_14_11_2
e_1_2_14_32_2
e_1_2_14_53_2
e_1_2_14_13_2
e_1_2_14_38_2
e_1_2_14_15_2
e_1_2_14_36_2
e_1_2_14_57_2
e_1_2_14_29_2
e_1_2_14_5_2
e_1_2_14_7_2
e_1_2_14_9_2
e_1_2_14_1_2
e_1_2_14_40_2
e_1_2_14_3_2
e_1_2_14_44_2
e_1_2_14_23_2
e_1_2_14_42_2
e_1_2_14_21_2
e_1_2_14_27_2
e_1_2_14_48_2
e_1_2_14_46_2
e_1_2_14_25_2
e_1_2_14_18_2
e_1_2_14_39_2
References_xml – ident: e_1_2_14_1_2
  doi: 10.1097/md.0000000000033724
– ident: e_1_2_14_4_2
  doi: 10.1111/j.1476-5381.2012.02194.x
– ident: e_1_2_14_45_2
  doi: 10.18632/aging.102625
– ident: e_1_2_14_31_2
  doi: 10.1161/01.cir.0000153339.27064.14
– ident: e_1_2_14_3_2
  doi: 10.1161/hypertensionaha.111.196832
– ident: e_1_2_14_25_2
  doi: 10.2144/000113083
– ident: e_1_2_14_58_2
  doi: 10.1161/atvbaha.118.311298
– ident: e_1_2_14_33_2
  doi: 10.1161/01.cir.0000131860.80444.ab
– ident: e_1_2_14_14_2
  doi: 10.1038/cddis.2017.495
– ident: e_1_2_14_39_2
  doi: 10.1161/01.cir.0000013836.85741.17
– ident: e_1_2_14_32_2
  doi: 10.1161/01.hyp.0000154365.30593.d3
– ident: e_1_2_14_18_2
  doi: 10.1016/j.yjmcc.2017.11.015
– ident: e_1_2_14_47_2
  doi: 10.1152/ajpendo.00192.2010
– ident: e_1_2_14_28_2
  doi: 10.1016/j.cell.2019.10.005
– ident: e_1_2_14_44_2
  doi: 10.1073/pnas.0707351104
– ident: e_1_2_14_49_2
  doi: 10.1152/ajpcell.00415.2006
– ident: e_1_2_14_51_2
  doi: 10.26355/eurrev_201902_16978
– ident: e_1_2_14_30_2
  doi: 10.18332/tid/140095
– ident: e_1_2_14_40_2
  doi: 10.1007/s10522-007-9082-x
– ident: e_1_2_14_41_2
  doi: 10.2174/13894501113149990191
– ident: e_1_2_14_53_2
  doi: 10.1016/j.vph.2020.106763
– ident: e_1_2_14_29_2
  doi: 10.3389/fphar.2021.758792
– ident: e_1_2_14_7_2
  doi: 10.1161/01.res.0000256837.40544.4a
– ident: e_1_2_14_22_2
  doi: 10.1016/j.toxlet.2017.07.216
– ident: e_1_2_14_13_2
  doi: 10.1038/cdd.2009.56
– ident: e_1_2_14_10_2
  doi: 10.1210/en.2010-0829
– ident: e_1_2_14_23_2
  doi: 10.1073/pnas.0801613105
– ident: e_1_2_14_55_2
  doi: 10.1038/nrd.2017.116
– ident: e_1_2_14_26_2
  doi: 10.1016/j.febslet.2012.12.021
– ident: e_1_2_14_27_2
  doi: 10.1002/2211-5463.12496
– ident: e_1_2_14_34_2
  doi: 10.1016/j.bbamcr.2011.07.010
– ident: e_1_2_14_57_2
  doi: 10.1038/s41568-022-00450-9
– ident: e_1_2_14_56_2
  doi: 10.1038/ncb3397
– ident: e_1_2_14_19_2
  doi: 10.1016/j.bbrc.2010.07.012
– ident: e_1_2_14_20_2
  doi: 10.1093/gerona/glu180
– ident: e_1_2_14_46_2
  doi: 10.1038/nature11919
– ident: e_1_2_14_50_2
  doi: 10.1155/2022/1388415
– ident: e_1_2_14_2_2
  doi: 10.3390/ijms20205214
– ident: e_1_2_14_43_2
  doi: 10.1158/0008-5472.can-07-2780
– ident: e_1_2_14_11_2
  doi: 10.1038/nrg1990
– ident: e_1_2_14_37_2
  doi: 10.1152/ajpcell.00203.2012
– ident: e_1_2_14_9_2
  doi: 10.12659/msm.920678
– ident: e_1_2_14_16_2
  doi: 10.1615/critreveukaryotgeneexpr.2015015396
– ident: e_1_2_14_36_2
  doi: 10.1291/hypres.31.1407
– ident: e_1_2_14_52_2
  doi: 10.1007/s00018-021-03979-4
– ident: e_1_2_14_6_2
  doi: 10.1097/hjh.0b013e328013f492
– ident: e_1_2_14_12_2
  doi: 10.1016/j.bbrc.2009.06.075
– ident: e_1_2_14_42_2
  doi: 10.1186/s13046-019-1059-5
– ident: e_1_2_14_54_2
  doi: 10.1371/journal.pone.0100359
– ident: e_1_2_14_17_2
  doi: 10.1113/jp272512
– ident: e_1_2_14_15_2
  doi: 10.3390/antiox8090328
– ident: e_1_2_14_35_2
  doi: 10.1097/fjc.0b013e31828c090e
– ident: e_1_2_14_8_2
  doi: 10.1038/srep31758
– ident: e_1_2_14_48_2
  doi: 10.1038/nrg3272
– ident: e_1_2_14_5_2
  doi: 10.1016/j.jsbmb.2011.12.014
– ident: e_1_2_14_24_2
  doi: 10.3389/fcvm.2021.784044
– ident: e_1_2_14_38_2
  doi: 10.1111/ggi.13927
– ident: e_1_2_14_21_2
  doi: 10.1155/2017/2872156
SSID ssj0000390398
Score 2.3324132
Snippet Inappropriate aldosterone production relative to sodium status is known to induce arterial hypertension and cause detrimental effects on endothelium and...
SourceID doaj
proquest
gale
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
StartPage 2339598
SubjectTerms Aldosterone
Apoptosis
Bioinformatics
Cardiovascular disease
Cell cycle
Cell growth
Corticosteroids
Endothelium
Genes
Hypertension
MicroRNA
MicroRNAs
Reagents
Senescence
Telomerase
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LbtQw0EI9IC6INwstGAnEydrUr9jHgFpVSNsDLFJvlu2MBajKVtvtgb_vjJNddeHAhWs8ecyM5xXPg7H3RaqeRm0IByoJ3ZtGOFtAWJClbc1xNpGqkRfn9uy7_nJhLu6M-qKcsLE98Ei4uaeJSjlFwBBQG9U4X0pBq6Ig-pQASPuizbsTTFUdjKG88m6b6W7M_OevH7_nUilvvNuzQbVV_98K-Q83s5qb00fs4eQn8m78vsfsHgxP2P3FdBL-lC0XlEn39bwTSke-qAM34JqjO8e7y54qN9arAQRN5sjQ8y5ntC8jt_mq8JOhp9KrS9x9_Bupu0wS_owtT0-Wn8_ENCFBZN24jXBZ574pkDXEBOi8ID8s9AVRz1mW7HXKx941yRfVohUCAGtS0UXGHmyrnrODAT_mJePORW9ycroA2quCcVSSPR3qoQZojY0z9mFLsnA19sEINX4wJhBpw0TaGftE9NzBUPfqegF5Giaehn_xdMbeEjfCWAq6k8HQobuoJGocfM3HCkFSuFnHHKdiAkSG-lntQR7uQaL05P3lLcfDJL3XAfUc9cHzjZ2xd7tlupMy0gZY3YwwHv0jg494Me6UHdIYk0uLeL36H8R4zR5Imjlcf_scsoPN-gaO0BHapDd1z98C1I8G9g
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegkxAvE98UBgQJxJNVL7YT-wllqNOE1AqNIu3Nip3zAE3J1nYP_PfcJW5QQeK1uab1fZ_tux9j72IuG4La4Aak56rRgpsiAi8gj2Wpj4OuqRt5sSzOvqnPF_oibbht0rXKnU_sHXXTBdojn6Hu0WwyK4qP1zecUKPodDVBaNxlB-iCjZmwg5P58sv5uMsisKSXPSBuLqzgQhq1u_2u9ezHz--_ZrmUVluzF5f68f3_Oum_Us8-BJ0-YIcpd8yqQdgP2R1oH7F7i3Q6_pitFnS77nxZcanqbNGDcMAmwxQvq64a6uZYdy1wQusI0GRVCBhzBg3IupjN24basa5QI7Ov5AIDWf0Ttjqdrz6d8YSawIMSZstNUKEREYKC2gMmNCijApqIbAghj8EqH46tEd5GWWJkAoBC-6hiXjdQlPIpm7T4Z56zzJja6uCNioAxLGJt5fOGDvrQK5S6qKfs_Y5l7nqYjeH6mkJrR6x1ibVTdkL8HGloonX_Qbe-dMlAnCXkrOBrwFJfaSmMjTFi9iChtt4DTNkbkoYb2kNHu3QVppASRS_wZz70FGSZ23Ud6tRggIuhGVd7lEd7lGhRYf_xTuIuWfTG_dG_KXs7PqZv0i21FrrbgcZizqTxFc8GTRkXjXV6XuC6Xvz_5S_Z_ZwQhvtNniM22a5v4RWmPVv_Oun2b2MJAH4
  priority: 102
  providerName: ProQuest
Title MicroRNA‐34a Mediates the Aldosterone‐Induced Acceleration of Endothelial Senescence
URI https://www.ncbi.nlm.nih.gov/pubmed/40226530
https://www.proquest.com/docview/3189548906
https://www.proquest.com/docview/3189921858
https://doaj.org/article/96542cbaeeb2453089fff2663ea9bbee
Volume 2025
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF9qC-KL-O1pPSMoPsWmu9lk90EklStFyaH1Cn1bdjezfnDkNL2C_e-d2SQHV8WXEJLJx87OZ7IzP8ZeBi4agtpIFQiX5o3MUlUESAvgoSzloZeWqpHreXFyln84l-c7bEQbHRh48c_UjvCkzrrlm9-_rt6hwr-NCi_lwfcf364OuBBaanWD7aFPKgnLoB4C_WiTMbUXERiXZzpLcZ-Pq-Cv3WDLP8U2_n8b62shaHRFx3fY7SGGTKp-0u-yHWjvsZv18Jf8PlvUtMrudF6lIrdJHcE44CLBUC-plg1VdXSrFlJC7fDQJJX36Ht6SUhWIZm1DZVlLVEyky9kCj1p_wO2OJ4t3p-kA3pC6vNMrVPlc99kAXwO1gEGNjhXBTQB2eA9D17nzh9qlTkdRIkeCgAK6UIeuG2gKMVDttviyzxmiVJWS-9UHgB9WcAcy_GGfvihdShlYSfs1cgy87PvkWFibiGlIdaagbUTdkT83NBQZ-t4YNV9NYOiGE0IWt5ZwJQ_lyJTOoSAUYQAq50DmLDnNBumLxPd6KepMJQUHK0RPuZ1pCCZWXfW26HQAAdDva62KPe3KFGz_PbpccbNKJgGbSD1yNNZMWEvNqfpSlqt1sLqsqfRGDtJvMWjXlI2g8Z8nRc4rif_f_ZTdosT0nD82LPPdtfdJTzD8GftpmzvaDb_dDqNnw9w-_GzmkZp_wPKtAT3
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKKgEXxJtAoYtExcmK68fGPiCUQqqUNhEqQerNWnvHPFQlJUmF-qP4j8zsIyggcau0p91Z73o8_mb8GH-MvUpSlUS1wS2owHVpBLd5Ap6DTP2-2Y-moGzk8SQffdYfzszZFvvV5sLQtsoWEyugLueR5sh7aHt0NpkT-duLH5xYo2h1taXQqM3iGK5-4pBt-eboPbbvnpSHw-m7EW9YBXjUwq64jTqWIkHUUARAh491yKFMytkYZYpOh4gjcRFcUn1EbgDITUg6yaKEvK-w2BtsW6tcyA7bPhhOPp6uJ3WEcnhVLHjCCS6U1e1me2N6375_vepJpZxxdsMNVmwB__qEvyLdyuMd3mV3mlA1G9S2dY9twew-uzluFuMfsOmYNvOdTgZc6SIbV5wfsMwwoswG5yUljyzmM-BEDhKhzAYxoourDS6bp2w4Kyn76xw7QPaJEDcSyDxk0-tQ5yPWmeHPPGGZtYUzMVidAF1mwqFckCWtKyII9U1edNleqzJ_UR_F4ashjDGeVOsb1XbZAelzLUMHaFc35osvvumP3hFRVwwFQJDaKGFdSgmDFQWFCwGgy3apNXydjbqGAT_AiFVJBD38zOtKgoBgtShi0eQzYGXoSK0NyZ0NSezAcfNx2-K-AZCl_2PuXfZy_ZjepE1xM5hf1jIOQzSDRTyuLWVdaY2xWY71evr_wnfZrdF0fOJPjibHz9htSeTG1fzSDuusFpfwHCOuVXjR2HnG_DX3rN9SJkA_
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKKlVcEG8ChS4SFScrix-79gGhlCZqKYmqEqTerLV3zENVtiSpUH8a_46ZfQQFJG6VcspOnPV45psZe8bD2KsoZEmtNrgB6bkqdcpNFoFnIGKe6zdBF1SNPJlmR5_Vh3N9vsV-dbUwlFbZYWIN1GUVaI98gLJHd5PZNBvENi3i9HD87vIHpw5SdNLatdNoROQErn9i-LZ8e3yIa70vxHg0e3_E2w4DPKjUrLgJKpRphKCg8IDGH-eTQRmlNSGIGKzyAaPy1Nsoc0RxAMi0jyqKooQslzjsLbadU1DUY9sHo-np2XqDJ5UWP3VHvNSmPJVGdYn3Wg--ff96PRBSWm3NhkmsOwf8ax_-8npr6ze-y-60bmsybOTsHtuC-X22M2kP5h-w2YQS-86mQy5VkUzq_h-wTNC7TIYXJRWSLKo5cGoUEqBMhiGguWuEL6liMpqXVAl2gcqQfCL0DQQ4D9nsJtj5iPXm-DJPWGJMYXXwRkVA8xkxrPOipDNGBKRcZ0Wf7Xcsc5fNtRyuDme0dsRa17K2zw6In2sauky7_qJafHGtbjpLTbuCLwC8UFqmxsYY0XGRUFjvAfpsj1bDNZWpa0hwQ_RepUAAxL95XVMQKKwWRSja2gacDF2vtUG5u0GJyhw2H3cr7lowWbo_ot9nL9eP6ZeUIDeH6qqhseiuaRzicSMp60kr9NMynNfT_w--x3ZQo9zH4-nJM3ZbUJ_jeqtpl_VWiyt4js7Xyr9oxTxh7oYV6zcSCER0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA-34a+Mediates+the+Aldosterone-Induced+Acceleration+of+Endothelial+Senescence&rft.jtitle=International+journal+of+hypertension&rft.au=Jia%2C+Minyue&rft.au=Lin%2C+Liya&rft.au=Yang%2C+Boyun&rft.au=Yu%2C+Hanxiao&rft.date=2025-01-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=2090-0392&rft.volume=2025&rft_id=info:doi/10.1155%2Fijhy%2F2339598&rft.externalDocID=A835328808
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2090-0392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2090-0392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2090-0392&client=summon